What You Should Know:
– Eko Health, a leader in AI-powered cardiac and pulmonary care, announced today that its telehealth platform is now used by health systems that operate over 800 hospitals across the U.S.
– By…
Continue Reading
What You Should Know:
– Eko Health, a leader in AI-powered cardiac and pulmonary care, announced today that its telehealth platform is now used by health systems that operate over 800 hospitals across the U.S.
– By…
Continue Reading
Background: The delivery of timely and appropriate care is crucial for survival in patients experiencing ST-elevation myocardial infarction (STEMI). Efficient communication and exchange of test results between the referring emergency medicine (EM) physician or…
Continue Reading
Findings from a previous study (ClinicalTrials.gov: NCT05118035) demonstrated that an AI-enabled electrocardiogram (AI-ECG), combining AI reports and physician alerts, effectively identified hospitalized patients at high risk of mortality and reduced all-cause mortality. This study…
Continue Reading
Artificial intelligence (AI)-ECG-derived age (AI-ECG age) and Heart Delta Age (HDA)—the difference between AI-ECG and chronological age—are emerging tools for assessing cardiovascular health. We systematically searched PubMed, Embase, Web of Science, and Scopus from…
Continue Reading
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection.
What You Should Know:
– AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its…
Continue Reading
Transforming cardiac care with single-lead ECG technology
Heart failure affects millions worldwide, but early detection remains challenging. A groundbreaking study published in JAMA Cardiology demonstrates how artificial intelligence can transform cardiac care using simple, single-lead…
ECG diagnostics software platform AccurKardia and cardiac medical technology company HeartBeam are joining forces to make AccurKardia’s ECG analysis software available on HeartBeam’s devices. HeartBeam’s cable-free, 12-lead ECG system captures electrical signals from the heart…
Continue Reading
What You Should Know:
– Researchers at Mount Sinai have enhanced an existing artificial intelligence (AI) algorithm to provide specific numeric probabilities identifying patients at risk for hypertrophic cardiomyopathy (HCM), a common inherited heart condition,…
Continue Reading
What You Should Know:
– HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a strategic collaboration with AccurKardia, an innovator in ECG-based diagnostics technology.
– The partnership…
Continue Reading
